Inovium Ovarian Rejuvenation Trials
Public ClinicalTrials.gov record NCT03178695. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Autologous Platelet-Rich Plasma (PRP) Infusions and Biomarkers of Ovarian Rejuvenation and Aging Mitigation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Inovium Ovarian Rejuvenation Treatment is a PRP-based autologous treatment used in combination with a stimulated IVF sequence and Pre-Implantation Genetic Screening to treat infertility in women experiencing menopause, perimenopause, and premature ovarian failure.
Study identification
- NCT ID
- NCT03178695
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 200 participants
Conditions and interventions
Conditions
- Perimenopausal Disorder
- Menopause
- Menopause, Premature
- Menopause Related Conditions
- Menopause Premature Symptomatic
- Menopause Premature Asymptomatic
- Premature Ovarian Failure
- Premature Ovarian Failure, Familial
- Premature Ovarian Failure 2A
- Premature Ovarian Failure 3
- Premature Ovarian Failure 4
- Premature Ovarian Failure 1
- Premature Ovarian Failure 5
- Premature Ovarian Failure 6
- Premature Ovarian Failure 7
- Premature Ovarian Failure 9
- Premature Ovarian Failure 8
- Infertility
- Infertility, Female
- Infertility Unexplained
Eligibility (public fields only)
- Age range
- 35 Years and older
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2017
- Primary completion
- Apr 30, 2018
- Completion
- Apr 30, 2018
- Last update posted
- Apr 19, 2020
2017 – 2018
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Center for Advanced Genetics | Carlsbad | California | 92008 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03178695, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 19, 2020 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03178695 live on ClinicalTrials.gov.